We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BG icon
451
Bunge Global
BG
$20.8B
$3.28M 0.02%
+58,813
New +$3.14M
SPR
452
DELISTED
Spirit AeroSystems
SPR
$3.27M 0.02%
40,121
+31,923
+389% +$2.69M
IAA
453
DELISTED
IAA, Inc. Common Stock
IAA
$3.26M 0.02%
+84,046
New +$3.26M
VISN
454
Vistance Networks Inc
VISN
$2.52B
$3.23M 0.02%
+205,339
New +$4.17M
KR icon
455
Kroger
KR
$34.8B
$3.22M 0.02%
+148,435
New +$3.61M
MGA icon
456
Magna International
MGA
$18.8B
$3.21M 0.02%
64,455
+43,049
+201% +$2.13M
OXM icon
457
Oxford Industries
OXM
$552M
$3.2M 0.02%
42,168
+42,167
+4,216,700% +$3.23M
MASI
458
DELISTED
Masimo
MASI
$3.19M 0.02%
21,459
-32,750
-60% -$4.49M
AVNS
459
DELISTED
Avanos Medical
AVNS
$3.19M 0.02%
73,072
+27,499
+60% +$1.18M
MCRB icon
460
Seres Therapeutics
MCRB
$48.4M
$3.13M 0.02%
48,647
+48,572
+64,763% +$4.61M
ETRN
461
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$3.13M 0.02%
158,605
+155,305
+4,706% +$3.23M
SAM icon
462
Boston Beer
SAM
$1.92B
$3.1M 0.02%
8,212
+8,012
+4,006% +$2.54M
TCF
463
DELISTED
TCF Financial Corporation Common Stock
TCF
$3.07M 0.02%
74,552
-90,771
-55% -$3.77M
HLX icon
464
Helix Energy Solutions
HLX
$1.41B
$3.06M 0.02%
355,048
+80,131
+29% +$623K
IART icon
465
Integra LifeSciences
IART
$1.34B
$3.03M 0.02%
54,273
-4,124
-7% -$212K
TJX icon
466
TJX Companies
TJX
$178B
$3.03M 0.02%
57,300
+8,890
+18% +$473K
VOYA icon
467
Voya Financial
VOYA
$9.19B
$3.03M 0.02%
54,740
+38,609
+239% +$2.07M
VFC icon
468
VF Corp
VFC
$5.89B
$3.01M 0.02%
34,477
+32,990
+2,219% +$2.84M
VLO icon
469
Valero Energy
VLO
$85.9B
$3.01M 0.02%
35,159
+3,258
+10% +$269K
AIZ icon
470
Assurant
AIZ
$14.3B
$3.01M 0.02%
28,253
-31,019
-52% -$3.07M
RUTH
471
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
$2.97M 0.02%
+130,818
New +$3.2M
NDLS icon
472
Noodles & Co
NDLS
$107M
$2.93M 0.02%
46,464
+45,308
+3,919% +$2.62M
CVLT icon
473
Commault Systems
CVLT
$5.61B
$2.93M 0.02%
58,957
-13,604
-19% -$723K
BALY icon
474
Bally's
BALY
$658M
$2.92M 0.02%
+98,244
New +$3.06M
JACK icon
475
Jack in the Box
JACK
$335M
$2.92M 0.02%
35,855
+33,562
+1,464% +$2.71M

Similar funds

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.